BrdU pulse-labeled cells in bone marrow and spleen
| Fraction . | Phenotype . | % of BrdU+ cells in fraction* (day of peak labeling) . |
|---|---|---|
| Bone marrow | ||
| A-D | CD45R+IgM−IgD− | 50.0 (1 d) |
| E | IgM+IgD− | 47.0 (2 d) |
| NF/T1 | IgMhiIgDloCD21lo | 38.2 (2 d) |
| F-II | IgDhiIgMhiCD21int | 19.5 (3 d) |
| F-I | IgDhiIgMlo | 7.5 (3 d) |
| Spleen | ||
| NF/T1 | IgMhiIgDlo/−CD21lo | 18.7 (2 d)† |
| F-II | IgDhiIgMhiCD21int | 6.2 (3 d) |
| F-I | IgDhiIgMlo | 3.5 (5 d) |
| Fraction . | Phenotype . | % of BrdU+ cells in fraction* (day of peak labeling) . |
|---|---|---|
| Bone marrow | ||
| A-D | CD45R+IgM−IgD− | 50.0 (1 d) |
| E | IgM+IgD− | 47.0 (2 d) |
| NF/T1 | IgMhiIgDloCD21lo | 38.2 (2 d) |
| F-II | IgDhiIgMhiCD21int | 19.5 (3 d) |
| F-I | IgDhiIgMlo | 7.5 (3 d) |
| Spleen | ||
| NF/T1 | IgMhiIgDlo/−CD21lo | 18.7 (2 d)† |
| F-II | IgDhiIgMhiCD21int | 6.2 (3 d) |
| F-I | IgDhiIgMlo | 3.5 (5 d) |